BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 18024945)

  • 21. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
    Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of cardiac troponin T elevation is independent of renal function and clinical findings in heart failure patients.
    Orea-Tejeda A; Sánchez-González LR; Castillo-Martínez L; Valdespino-Trejo A; Sánchez-Santillán RN; Keirns-Davies C; Colín-Ramírez E; Montańo-Hernández P; Dorantes-García J
    Cardiol J; 2010; 17(1):42-8. PubMed ID: 20104456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
    Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
    Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery.
    Kertai MD; Boersma E; Klein J; Van Urk H; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):59-66. PubMed ID: 15177233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.
    Hudson MP; O'Connor CM; Gattis WA; Tasissa G; Hasselblad V; Holleman CM; Gaulden LH; Sedor F; Ohman EM
    Am Heart J; 2004 Mar; 147(3):546-52. PubMed ID: 14999208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction.
    Löwbeer C; Gustafsson SA; Seeberger A; Bouvier F; Hulting J
    Scand J Clin Lab Invest; 2004; 64(7):667-76. PubMed ID: 15513324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.
    Prasad A; Singh M; Lerman A; Lennon RJ; Holmes DR; Rihal CS
    J Am Coll Cardiol; 2006 Nov; 48(9):1765-70. PubMed ID: 17084247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect on outcome of an increase of serum cardiac troponin T in patients with healing or healed ST-elevation myocardial infarction.
    Shimizu M; Sato H; Sakata Y; Nakatani D; Mizuno H; Suna S; Fujii K; Ueda Y; Nanto S; Hori M;
    Am J Cardiol; 2007 Dec; 100(12):1723-6. PubMed ID: 18082515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
    Gheorghiade M; Gattis Stough W; Adams KF; Jaffe AS; Hasselblad V; O'Connor CM
    Am J Cardiol; 2005 Sep; 96(6A):18G-25G. PubMed ID: 16181819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
    Egstrup M; Schou M; Tuxen CD; Kistorp CN; Hildebrandt PR; Gustafsson F; Faber J; Goetze JP; Gustafsson I
    Am J Cardiol; 2012 Aug; 110(4):552-7. PubMed ID: 22579083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac troponin T and end stage renal disease.
    Gabr AE; Ibrahim IA; Aloulou SM; Al-Alfi MA; Al-Abdlrahim KA
    Saudi Med J; 2004 Aug; 25(8):1015-9. PubMed ID: 15322590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: a report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study.
    Perna ER; Aspromonte N; Cimbaro Canella JP; Di Tano G; Macin SM; Feola M; Coronel ML; Milani L; Parras JI; Milli M; García EH; Valle R
    J Card Fail; 2012 Nov; 18(11):822-30. PubMed ID: 23141854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.
    O'Connor CM; Fiuzat M; Lombardi C; Fujita K; Jia G; Davison BA; Cleland J; Bloomfield D; Dittrich HC; Delucca P; Givertz MM; Mansoor G; Ponikowski P; Teerlink JR; Voors AA; Massie BM; Cotter G; Metra M
    Circ Heart Fail; 2011 Nov; 4(6):724-32. PubMed ID: 21900185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour Necrosis Factor alpha and Troponin T as predictors of poor prognosis in patients with stable heart failure.
    Rodríguez-Reyna TS; Arrieta O; Castillo-Martínez L; Orea-Tejeda A; Guevara P; Rebollar V; Granados J
    Clin Invest Med; 2005 Feb; 28(1):23-9. PubMed ID: 15770879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemia-modified albumin predicts mortality in ESRD.
    Sharma R; Gaze DC; Pellerin D; Mehta RL; Gregson H; Streather CP; Collinson PO; Brecker SJ
    Am J Kidney Dis; 2006 Mar; 47(3):493-502. PubMed ID: 16490629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival and cardiac troponin T elevation in on- and off-pump coronary artery bypass surgery.
    Brown JR; Hernandez F; Klemperer JD; Clough RA; DiPierro FV; Hofmaster PA; Ross CS; O'Connor GT
    Heart Surg Forum; 2008; 11(3):E163-8. PubMed ID: 18583287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.